BPA exposure in U.S.-approved levels may alter insulin response in non-diabetic adults
Researchers have found that a common chemical consumers are exposed to several times a day may be altering insulin release. Results of the study indicate that the FDA-approved “safe” daily exposure amount of BPA may be enough to have implications for development of Type 2 diabetes. September 13, 2018